|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/48 | (2006.01) |
| A61K 31/4178 | (2006.01) | ||
| A61K 47/02 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 4138790 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21724012.6 |
| Date of filing the European patent application | 2021-04-23 | |
| (97) | Date of publication of the European application | 2023-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-31 |
| (46) | Date of publication of the claims translation | 2024-04-10 |
| (86) | Number | PCT/GB2021/050994 |
| Date | 2021-04-23 |
| (87) | Number | WO 2021/214488 |
| Date | 2021-10-28 |
| (30) | Number | Date | Country code |
| 202006079 | 2020-04-24 | GB |
| (72) |
CAMBER, Ola , SE
EVERAERT, Arnout , BE
GRUDÉN, Stefan , SE
|
| (73) |
Vicore Pharma AB ,
Kornhamnstorg 53, 111 27 Stockholm,
SE
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Naujoji sausų miltelių sudėtis, skirta peroraliniam vartojimui |
| NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION |
| Payment date | Validity (years) | Amount | |
| 2025-04-07 | 5 | 115.00 EUR |
| 2026-04-23 |